Stock Taper
SIGA Technologies, Inc., a NY-based pharmaceutical company founded in 1995, specializes in infectious disease and health security, with its main product TPOXX for smallpox treatment and a partnership with Cipla Therapeutics for antibacterial drugs.

TPOXX, FDA-approved for smallpox and also used for monkeypox, cowpox, and vaccinia complications, is SIGA's flagship antiviral and a vital part of biodefense stockpiles against orthopoxviruses.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Product Sales and Supportive Services | $889.75K | $2.21M ▲ | $3.54M ▲ | $37.87M ▲ |
![]() | Research and Development | $1.73M | $1.58M ▼ | $2.7M ▲ | $3.13M ▲ |
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | UNITED STATES | $2.62M | $3.79M ▲ | $6.24M ▲ | $28.03M ▲ |
![]() | NonUS | — | $0 | — | $12.97M ▲ |
![]() | Asia Pacific | — | — | — | $12.7M |
![]() | EMEA | — | — | — | $272.54K |
![]() | CANADA | — | $0 | — | — |
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
OLMA | $10.27 | COMPARE |
RIGL | $46.48 | COMPARE |
CTMX | $3.21 | COMPARE |
AQST | $5.02 | COMPARE |
SNDL | $1.35 | COMPARE |
EBS | $5.91 | COMPARE |
ORGO | $1.74 | COMPARE |
DRIO | $6.77 | COMPARE |